Arlo (ARLO) Q1 2026 earnings review
SaaS Transformation Complete: Record Profitability Defines Arlo's Q1
Arlo has officially completed its pivot from a low-margin hardware manufacturer to a high-margin SaaS platform. Q1 2026 results were exceptional: total revenue grew 26% YoY, propelled by a 31% surge in high-margin subscription and services revenue. The operational leverage is massive, with adjusted EBITDA spiking 85% YoY to $30.4 million. While product margins remain negative as Arlo aggressively subsidizes hardware to acquire users, the lifetime value of these subscribers makes the math work. The acquisition of Aloe Care Health signals management's confidence in leveraging its balance sheet to expand into adjacent AI-powered markets. Guidance suggests growth will slightly decelerate into Q2, but the profitability profile remains incredibly strong.
🐂 Bull Case
Arlo's subscription revenue now accounts for nearly 60% of total sales. With ARR growing 29% and an adjusted EBITDA margin of 20.2%, Arlo is executing as an elite SaaS business with highly predictable cash flows.
The company surpassed the 6 million paid account milestone, up 22.6% YoY. Customer acquisition costs are heavily subsidized by hardware discounts, but 85.4% non-GAAP service gross margins ensure rapid payback periods.
🐻 Bear Case
Product gross margins remain stubbornly negative (GAAP -4.6%). Arlo is essentially buying its subscribers by taking losses on cameras. If subscriber churn spikes, the unit economics of this strategy will collapse.
Management explicitly warned about an uncertain global tariff environment. Because hardware is manufactured overseas, rising tariffs could further depress product margins and increase customer acquisition costs.
⚖️ Verdict: 🟢🟢
Bullish. Arlo's execution is stellar. The company has proven its thesis that heavily discounting hardware leads to highly sticky, wildly profitable recurring revenue streams. The transition is paying off exponentially on the bottom line.
Key Themes
Accelerating Subscription Engine
Subscriptions and services are the lifeblood of Arlo, accounting for 59.9% of total Q1 revenues ($90.1M). Growth is accelerating, pushing Annual Recurring Revenue (ARR) to $356.9M (+29.2% YoY). Most impressively, non-GAAP service gross margins expanded to 85.4% (up 230 basis points YoY), driving the massive bottom-line beat.
AI Innovation via Aloe Care Acquisition
Arlo announced the acquisition of Aloe Care Health in April 2026. This marks a strategic shift from pure property security into AI-powered services for aging-in-place care. This expands Arlo's Total Addressable Market (TAM) significantly and allows them to cross-sell a new recurring service into their existing 6 million household base.
EMEA Region Reversing to High Growth
EMEA revenues surged 41.4% YoY to $60.6M, representing 40.3% of total revenue. This is a sharp reversal from historical volatility tied to partner inventory stocking cycles in the region, indicating stabilized and accelerating international sell-through demand.
Hardware Sold at a Loss
Non-GAAP product gross margins were stable but negative at -2.8% (GAAP -4.6%). This confirms management's strategy of using hardware entirely as a loss-leading customer acquisition tool. While currently effective, this creates structural vulnerability if competitive pricing forces Arlo to subsidize hardware even further.
Macro Risks: The Tariff Squeeze
Management explicitly cited the uncertain global tariff environment in their guidance. Arlo's products are manufactured outside the U.S., meaning tariffs directly hit the already-negative product gross margin line. Any escalation in trade tensions directly increases Arlo's Customer Acquisition Cost (CAC).
APAC Region Contradicts Global Growth Narrative
While management touts massive global adoption and Americas/EMEA posted strong double-digit growth, the APAC region is lagging severely. APAC revenue fell 5.6% YoY from $6.07M in 25Q1 to $5.73M in 26Q1. This localized deceleration suggests market share losses to regional competitors or flawed go-to-market execution in Asia.
Other KPIs
FCF margin came in at a highly robust 16.9%. While slightly decelerating from 25Q1's record $28.1M (23.6% margin), cash generation is extremely healthy, providing ample liquidity for the $8M stock buyback and the Aloe Care acquisition.
Balance sheet remains a fortress. Cash position grew $14.4M YoY, even after funding strategic investments, repurchasing shares, and absorbing the working capital required to support Q1 hardware volumes.
Guidance
Decelerating. The $150M midpoint implies roughly 15.9% YoY growth against 25Q2's $129.4M. While still strong double-digit growth, this is a noticeable step down from the 26.3% YoY growth delivered in the current quarter.
Decelerating. The midpoint of $0.20 implies 17.6% YoY growth versus the $0.17 printed in 25Q2. Sequentially, this points to an expected dip from 26Q1's record $0.28, likely reflecting the integration costs of Aloe Care or planned promotional pricing for hardware.
Key Questions
Aloe Care Integration
With the acquisition of Aloe Care Health, what is the timeline for integrating their AI-powered aging-in-place services into the core Arlo Secure platform, and how will it be priced for existing subscribers?
Tariff Mitigation Tactics
Guidance incorporates 'current estimates on tariff costs.' If trade tensions escalate and tariffs increase significantly, does Arlo plan to raise retail hardware prices, or will it absorb the hit to protect subscriber acquisition volume?
APAC Weakness
APAC was the only region to post negative YoY revenue growth. What specific competitive or macroeconomic dynamics are driving this lag, and what is the turnaround plan for the region?